I don't know how you interpreted the letter so negatively, it was informative and honest. The trials were positive. SP isn't reflective of where we should be, in my opinion this is mostly because of delays and missed deadlines, if this letter was 6 months ago we would be over 10 cents, as it stands we needed better results. Sharing data with pharma companie, I would like to see this data it should be presented to shareholders.
Ann: Letter to Shareholders, page-5
-
- There are more pages in this discussion • 106 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
